Search results
Results from the Go Local Guru Content Network
Cramer repeated, referring to his own quote during a March 11, 2008 segment of Mad Money. Moreover, Cramer outlined, But through a clever sound bite, Stewart, and subsequently Rich—neither of whom have bothered to listen to the context of the pulled quote—pass off the notion of account safety as an out-and-out buy recommendation.
This sale price represented a staggering loss as its stock had traded at $172 a share as late as January 2007, and $93 a share as late as February 2008. Eventually, after renegotiating the purchase of Bear Stearns, Maiden Lane LLC was funded by a $29 billion first priority loan from FRBNY and a $1 billion subordinated loan from JPMorgan Chase ...
Boston Scientific Corporation (BSC), headquartered in Watertown, Massachusetts and incorporated in Delaware, is a biomedical/biotechnology engineering firm and multinational manufacturer of medical devices used in interventional medical specialties, including interventional radiology, interventional cardiology, peripheral interventions, neuromodulation, neurovascular intervention ...
What does the hottest stock in the S&P 500 do after skyrocketing more than any other large-cap stock on the market? Announcing a major stock split could be a good follow-up. That's exactly what ...
The New York Stock Exchange got it wrong, listing Berkshire Hathaway's (NYSE: BRK.A) (NYSE: BRK.B) A shares as having lost some 99% of their value. That didn't really happen, but that's what the ...
A deception plan in the weeks ahead of the attack had led them to expect the main invasion further along the coast. The surprise element helped British troops establish a foothold on a beach ...
WALTHAM, MA — When Boston Sports Clubs shut the doors on a dozen of its gyms this fall amid financial trouble for the chain, it sent members from the now closed Watertown and West Newton ...
Guidant's stock price rose 10% on the news. The offer was not actually finalized until after due diligence had been completed on January 8, 2006. Counter-offers. On January 11, 2006, Johnson & Johnson presented a counteroffer of $23.2 billion, still less than their original 2004 bid, which the Guidant board accepted.